tiprankstipranks
Advertisement
Advertisement
Prime Medicine: Prime Editing Platform and PM577 Create Compelling Risk‑Reward in Addressing Unmet Need in Wilson’s Disease
PremiumRatingsPrime Medicine: Prime Editing Platform and PM577 Create Compelling Risk‑Reward in Addressing Unmet Need in Wilson’s Disease
2M ago
Oppenheimer bullish on Prime Medicine, initiates with an Outperform
Premium
The Fly
Oppenheimer bullish on Prime Medicine, initiates with an Outperform
3M ago
Prime Medicine initiated with an Outperform at Oppenheimer
Premium
The Fly
Prime Medicine initiated with an Outperform at Oppenheimer
3M ago
Prime Medicine Advances Wilson Disease Pipeline With New Prescreening Study
PremiumCompany AnnouncementsPrime Medicine Advances Wilson Disease Pipeline With New Prescreening Study
4M ago
Prime Medicine updates corporate strategy for Prime Editing platform
Premium
Company Announcements
Prime Medicine updates corporate strategy for Prime Editing platform
5M ago
Ametek, MindMed, Atai, Prime and KB Home Trending
Premium
Weekend Updates
Ametek, MindMed, Atai, Prime and KB Home Trending
6M ago
Prime Medicine transferred with Neutral rating at JPMorgan
PremiumThe FlyPrime Medicine transferred with Neutral rating at JPMorgan
7M ago
Cautious Hold Rating for Prime Medicine, Inc. Amid Promising Preclinical Results and Extended Development Timeline
Premium
Ratings
Cautious Hold Rating for Prime Medicine, Inc. Amid Promising Preclinical Results and Extended Development Timeline
7M ago
Prime Medicine’s Promising Advances in Gene Editing Justify Buy Rating
Premium
Ratings
Prime Medicine’s Promising Advances in Gene Editing Justify Buy Rating
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100